![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1785133
µ¿¸Æ ÇÊÅÍ ½ÃÀå : ¼ºÀå, Àü¸Á, °æÀï ºÐ¼®(2025-2033³â)Arterial Filter Market - Growth, Future Prospects and Competitive Analysis, 2025 - 2033 |
¼¼°èÀÇ µ¿¸Æ ÇÊÅÍ ½ÃÀåÀº ½ÉÀå ¼ö¼ú °Ç¼ö Áõ°¡, ü¿Ü ¼øÈ¯ ±â¼úÀÇ Áøº¸, ½ÉÆó ¿ìȸ(CPB) ÀýÂ÷ Áß È¯ÀÚÀÇ ¾ÈÀü¼º Çâ»ó¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó 2025³âºÎÅÍ 2033³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 7.0%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. µ¿¸Æ ÇÊÅÍ´Â Ç÷¾×ÀÌ È¯ÀÚÀÇ Ã¼³»·Î ´Ù½Ã µé¾î°¡±â Àü¿¡ »öÀü, ±âÆ÷, ¹Ì¸³ÀÚ¸¦ Æ÷ÂøÇÏ°í ¼ö¼ú ÈÄ ÇÕº´ÁõÀ» ÃÖ¼ÒÈÇÏ´Â Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇÕ´Ï´Ù. ³ëÀÎ Àα¸ Áõ°¡, ½ÉÇ÷°ü ÁúȯÀÇ ÀÌȯÀ² Áõ°¡, ½ÅÈï ½ÃÀå¿¡¼ ¼ö¼ú¿¡ ´ëÇÑ Á¢±Ù¼º Áõ°¡°¡ ½ÃÀå ¼ö¿ä¸¦ °¡¼ÓÈÇϰí ÀÖ½À´Ï´Ù. ÇÊÅÍ Àç·áÀÇ Çõ½Å, ÇÁ¶óÀÌ¹Ö ¾çÀÇ ÃÖÀûÈ, Àΰø ½ÉÆó ÀåÄ¡¿ÍÀÇ ÅëÇÕÀÌ Á¦Ç° äÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÉÇ÷°ü Áúȯ ¹× ½ÉÀå ¼ö¼úÀÇ À¯º´·ü Áõ°¡
½ÉÇ÷°ü ÁúȯÀÇ ¼¼°è ºÎ´ãÀÌ Æ¯È÷ °í·ÉÈ Àα¸ »çÀÌ¿¡¼ ±ÞÁõÇÏ´Â µ¿¾È ¾ÈÀüÇϰí È¿À²ÀûÀΠü¿Ü ¼øÈ¯ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. µ¿¸Æ ÇÊÅÍ´Â ¹ÙÀÌÆÐ½º ȸ·Î¿¡ ÇʼöÀûÀÌ¸ç °ü»óµ¿¸Æ ¹ÙÀÌÆÐ½º À̽ļú(CABG), ÆÇ¸· ġȯ¼ú, ¼±Ãµ¼º °áÇÌ ¼öº¹¼ú ½Ã »öÀü ¹æÁö¸¦ º¸ÀåÇÕ´Ï´Ù. ƯÈ÷ °í¼Òµæ±¹°¡³ª ±Þ¼ÓÈ÷ ¹ßÀüÇÏ´Â ±¹°¡¿¡¼ ¼ö¼ú·®ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó º´¿ø°ú ¼ö¼ú¼¾ÅÍ´Â Àü½Å¼º ¿°Áõ¹ÝÀÀÀ» ¾ïÁ¦Çϰí ÀÓ»ó °á°ú¸¦ °³¼±Çϱâ À§ÇØ Ã·´Ü µ¿¸Æ ÇÊÅ͸¦ ä¿ëÇϰí ÀÖ½À´Ï´Ù.
ÇÊÅÍ Àç·á¡¤¼³°è¿¡ ÀÖ¾î¼ÀÇ ±â¼ú Çõ½Å
Á¦Á¶¾÷ü °¢»ç´Â Æú¸®ÇÁ·ÎÇÊ·», Æú¸®¿¡Æ¿·», PVC µîÀÇ »ýüÀûÇÕ¼ºÀ¸·Î ºñÇ÷Àü¼º Àç·á·Î ¸¸µé¾îÁø µ¿¸Æ ÇÊÅÍÀÇ °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¹°ÁúÀº ÃÖÀûÀÇ Ç÷¾× ÀûÇÕ¼º, ¾Ð·Â ¼Õ½Ç °¨¼Ò ¹× ¹Ì¼¼ »öÀü Á¦°Å °È¸¦ Á¦°øÇÕ´Ï´Ù. ÀúÈíÀη® ¼³°è, ¿±³È¯±â´ÉÀÇ ÅëÇÕ, ¹æ»ç»ó À¯·Î±¸¼º µîÀÇ Çõ½ÅÀûÀÎ ±â¼ú·Î »ç¿ë¼ºÀÌ Çâ»óµÇ°í, Ç÷¾× Èñ¼®ÀÌ °¨¼ÒÇϰí, ¼ö¼úÀÇ ¾ÈÀü¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¶¸³µÈ ÀÏȸ¿ë CPB ȸ·Î·ÎÀÇ À̵¿Àº ÄÄÆÑÆ®Çϰí È¿À²ÀûÀÎ ÇÊÅÍ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
ÀúÀÚ¿ø ȯ°æ¿¡¼ÀÇ ºñ¿ë°¨°¢°ú ÇÑÁ¤ÀûÀΠä¿ë
µ¿¸Æ ÇÊÅÍ ½ÃÀåÀº ÀÓ»óÀûÀÎ ÀÌÁ¡ÀÌ ÀÖÀ½¿¡µµ ºÒ±¸Çϰí Àú¼ÒµæÃþ°ú ºñ¿ë¿¡ ¹Î°¨ÇÑ Áö¿ª¿¡¼´Â ÷´Ü ¼ö¼ú¿ë ¼Ò¸ðǰ ºñ¿ëÀÌ »ó´ëÀûÀ¸·Î ³ô´Ù´Â °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. °ø¸³ º´¿ø ¹× ÀÚ±Ý ºÎÁ· ÀÇ·á ½Ã½ºÅÛÀº ±â¼ú Çõ½Åº¸´Ù ºñ¿ëÀÌ ¿ì¼±ÇÏ¸ç ±³Ã¼ ÁֱⰡ ´À·ÁÁö°Å³ª Àç»ç¿ë °¡´ÉÇÑ ±¸¼º ¿ä¼Ò¿¡ µû¶ó ´Þ¶óÁú ¼ö ÀÖ½À´Ï´Ù. ±ÔÁ¦»óÀÇ Àå¾Ö¹°°ú ´ÜÆíÀûÀÎ »óȯ Á¤Ã¥Àº Â÷¼¼´ë µ¿¸Æ ÇÊÅÍÀÇ ½Å¼ÓÇÑ Ã¤¿ëÀ» Á¦ÇÑÇÕ´Ï´Ù. °Ô´Ù°¡, Áö¿ª °£ÀÇ ÀÓ»óÀû ¼±È£µµÀÇ ÆíÂ÷¿Í Ç¥ÁØÈÀÇ °ÝÂ÷´Â Á¦Ç°ÀÇ º¸±Þ¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.
ÇÊÅÍ Àç·áº° ½ÃÀå ±¸ºÐ
½ÃÀåÀº Æú¸®ÇÁ·ÎÇÊ·», Æú¸®¿¡Æ¿·», PVC(PVC) ¹× ±âŸ ÇÊÅÍ Àç·á·Î ±¸ºÐµË´Ï´Ù. 2024³â¿¡´Â Æú¸®ÇÁ·ÎÇÊ·»ÀÌ »ýüÀûÇÕ¼ºÀÌ ³ôÀº ¿©°ú ÀåÄ¡¿¡ ³Î¸® »ç¿ëµÇ¾î ³ôÀº À¯·®°ú ÃÖ¼ÒÇÑÀÇ ¿ëÇ÷ À§ÇèÀ» Á¦°øÇϱ⠶§¹®¿¡ ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. Æú¸®¿¡Æ¿·»Àº Àúºñ¿ë°ú ±¸Á¶Àû À¯¿¬¼ºÀ¸·Î Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. PVC´Â ¿¹»êÀÌ ±î´Ù·Î¿î ¿ëµµ·Î °è¼Ó »ç¿ëµË´Ï´Ù. ±âŸ 'ºÎ¹®Àº ´Ü¹éÁú ºÎÂøÀ» ÁÙÀ̰í Ç÷Çà ¿ªÇÐÀ» °³¼±ÇϱâÀ§ÇÑ Â÷¼¼´ë ÀÀ¿ë ºÐ¾ß¸¦ À§ÇØ °³¹ßÁßÀΠ÷´Ü Æú¸®¸Ó ºí·»µå ¹× ÄÚÆÃ Àç·á¸¦ Æ÷ÇÔÇÕ´Ï´Ù.
ÇÁ¶óÀÌ¹Ö º¼·ýº° ½ÃÀå ±¸ºÐ
ÇÁ¶óÀÌ¹Ö º¼·ýº°·Î ½ÃÀåÀº 100mL ¹Ì¸¸, 100-200mL, 200mL ÀÌ»óÀ¸·Î ºÐ·ùµË´Ï´Ù. 100-200mL ºÎ¹®Àº Ç÷¾× Èñ¼® À§Çè°ú °ø±â Á¦°Å È¿À²ÀÇ ±ÕÇüÀ¸·Î 2024³â¿¡ °¡Àå Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ ¹üÀ§ÀÇ ÇÊÅÍ´Â ¼ºÀÎÀÇ ½ÉÀå ¼ö¼ú¿¡ ÀϹÝÀûÀ¸·Î »ç¿ëµË´Ï´Ù. 100mL ¹Ì¸¸ÀÇ ºÎ¹®Àº ȸ·Î ¿ë·®ÀÇ ÃÖ¼ÒȰ¡ ÇʼöÀûÀÎ ¼Ò¾Æ ¼ö¼ú°ú ³·Àº ħ½À ½ÉÀå ¼ö¼ú¿¡¼ÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ ±Þ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. 200mL ÀÌ»óÀÇ ºÎ¹®Àº ƯÈ÷ ´ÙÀå±â ÁöÁö ½Ã½ºÅÛ ¹× ´ëÇü ȯÀÚ¿Í °°Àº ƯÁ¤ °í À¯·®ÀÇ º¹ÀâÇÑ °æ¿ì¿¡ ÇØ´çÇÕ´Ï´Ù.
Áö¿ªº° µ¿Çâ
2024³â¿¡´Â ºÏ¹Ì°¡ µ¿¸Æ ÇÊÅÍ ½ÃÀå¿¡¼ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ´Â °³½É¼úÀÇ °Ç¼ö°¡ ¸¹Àº °Í, º´¿øÀÇ ÀÎÇÁ¶ó°¡ È®½ÇÈ÷ Çϰí ÀÖ´Â °Í, Çõ½ÅÀûÀÎ ÀÇ·á ±â¼úÀÌ ÀÏÂïºÎÅÍ Ã¤¿ëµÇ°í Àֱ⠶§¹®ÀÔ´Ï´Ù. À̾î À¯·´ÀÌ °è¼ÓµÇ¾î µ¶ÀÏ, ÇÁ¶û½º, ¿µ±¹ µî °íµµÀÇ ½ÉÀåÄ¡·á ½Ã½ºÅÛÀÌ ³Î¸® È®¸³µÇ°í ÀÖ´Â ±¹°¡¿¡¼ÀÇ º¸±ÞÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·áÅõÀÚ Áõ°¡, ½ÉÇ÷°üÁúȯ À¯º´·ü Áõ°¡, Áß±¹, Àεµ, µ¿³²¾Æ½Ã¾ÆÀÇ ¿Ü°úÀû °³ÀÔ¿¡ ´ëÇÑ Á¢±Ù¼º °³¼± µî¿¡ ÈûÀÔ¾î 2025³âºÎÅÍ 2033³â±îÁö °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«´Â ½ÅÈï ½ÃÀåÀÌ¸ç ½ÉÀå¿¡ ´ëÇÑ ÀǽÄÀÇ °íÁ¶¿Í °øÁß º¸°Ç¿¡ ´ëÇÑ ³ë·ÂÀÌ ¼ö¿ä¸¦ ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù.
°æÀï µ¿Çâ
µ¿¸Æ ÇÊÅÍ ½ÃÀåÀº Àû´çÈ÷ ÅëÇյǾî ÀÖÀ¸¸ç ±âÁ¸ ±â¾÷Àº R&D, Á¦Ç° ÅëÇÕ ¹× ÀÓ»ó ¾ÈÀü¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. Å׸£¸ð(TERUMO), ¸ÞµåÆ®·Î´Ð(Medtronic), ¸®¹Ù³ë¹Ù(LivaNova)´Â °ß°íÇÑ Æ÷Æ®Æú¸®¿À, °·ÂÇÑ ÆÇ¸Å ³×Æ®¿öÅ©, ÇÊÅÍ Àç·á ¹× È帧 ¿ªÇÐÀÇ Çõ½ÅÀ¸·Î ¼¼°è ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. NIPRO¿Í GETINGE´Â µ¿¸Æ ÇÊÅͰ¡ ¹øµéµÈ ÅëÇÕÇü ü¿Ü ¼øÈ¯ ½Ã½ºÅÛÀ» Á¦°øÇÕ´Ï´Ù. Pall Corporation ¹× SENKO Medical Instrument¿Í °°Àº ±â¾÷Àº Á¤¹Ð Á¤¹Ð ¿©°ú¿Í »ýü ÀûÇÕ¼º¿¡ ÁßÁ¡À» µÓ´Ï´Ù. EUROSETS, Braile Biomedica, Beijing MEDOS AT Biotechnology´Â ÇÕ¸®ÀûÀÎ °¡°ÝÀ¸·Î ±ÔÁ¦ Áؼö Á¦Ç°À» Á¦°øÇϰí Áö¿ªÀûÀ¸·Î È®´ëÇϰí ÀÖ½À´Ï´Ù. °æÀïÀÇ ¿ì¼± °úÁ¦´Â ³·Àº ÇÁ¶óÀÌ¹Ö ¾ç, CPB ½Ã½ºÅÛ°úÀÇ ¸ðµâ½Ä ÅëÇÕ, ¿ì¼öÇÑ ¼³°è ¹× ÄÚÆÃ ±â¼ú¿¡ ÀÇÇÑ ¿°Áõ ¹ÝÀÀ °¨¼Ò µîÀÔ´Ï´Ù.
The global arterial filter market is expected to grow at a CAGR of 7.0% from 2025 to 2033, driven by the increasing volume of cardiac surgeries, advancements in extracorporeal circulation technologies, and rising demand for improved patient safety during cardiopulmonary bypass (CPB) procedures. Arterial filters play a critical role in capturing emboli, air bubbles, and particulate matter before blood re-enters the patient's body, minimizing post-operative complications. The rising geriatric population, growing incidence of cardiovascular diseases, and increasing access to surgical interventions in emerging markets are accelerating market demand. Innovations in filter materials, priming volume optimization, and integration with heart-lung machines are further enhancing product adoption.
Market Drivers
Increasing Prevalence of Cardiovascular Disorders and Cardiac Surgeries
With the global burden of cardiovascular diseases rising sharply especially among aging populations - demand for safe and efficient extracorporeal circulation systems is growing. Arterial filters are integral to bypass circuits, ensuring embolic protection during coronary artery bypass grafting (CABG), valve replacement, and congenital defect repairs. As procedural volumes rise, particularly in high-income and rapidly developing countries, hospitals and surgical centers are adopting advanced arterial filters to reduce systemic inflammatory responses and improve clinical outcomes.
Technological Innovations in Filter Materials and Design
Manufacturers are focusing on the development of arterial filters made from biocompatible, non-thrombogenic materials such as polypropylene, polyethylene, and PVC. These materials offer optimal blood compatibility, reduced pressure drop, and enhanced microemboli removal. Innovations such as low-priming-volume designs, integrated heat exchange features, and radial flow configurations are improving usability, reducing hemodilution, and enhancing procedural safety. Additionally, the shift toward pre-assembled and disposable CPB circuits is driving demand for compact and efficient filter systems.
Market Restraint
Cost Sensitivity and Limited Adoption in Low-Resource Settings
Despite clinical benefits, the arterial filter market faces challenges in low-income and cost-sensitive regions due to the relatively high cost of advanced surgical disposables. Public hospitals and underfunded healthcare systems may prioritize cost over innovation, leading to slower replacement cycles or reliance on reusable components. Regulatory hurdles and fragmented reimbursement policies also limit swift adoption of next-generation arterial filters. Furthermore, variability in clinical preferences and standardization gaps across regions can affect product penetration.
Market Segmentation by Filter Material
The market is segmented into Polypropylene, Polyethylene, Polyvinyl chloride (PVC), and Other filter materials. In 2024, Polypropylene dominated the market due to its widespread use in biocompatible filtration devices, offering high flow rates and minimal hemolysis risk. Polyethylene is also gaining popularity due to its lower cost and structural flexibility. PVC continues to be used in budget-sensitive applications. The "Others" segment includes advanced polymer blends and coated materials under development for next-gen applications aiming to reduce protein adhesion and improve hemodynamic performance.
Market Segmentation by Priming Volume
By priming volume, the market is classified into Less than 100 mL, 100-200 mL, and More than 200 mL. The 100-200 mL segment held the largest revenue share in 2024 due to its balance between hemodilution risk and air removal efficiency. Filters in this range are commonly used in adult cardiac surgeries. The Less than 100 mL segment is expected to grow rapidly due to increasing adoption in pediatric surgeries and minimally invasive cardiac procedures, where minimizing circuit volume is essential. The More than 200 mL segment caters to specific high-flow and complex cases, particularly in multi-organ support systems or large patients.
Geographic Trends
In 2024, North America held the largest share of the arterial filter market, owing to high volumes of open-heart surgeries, strong hospital infrastructure, and early adoption of innovative medical technologies. Europe followed, with strong penetration in countries like Germany, France, and the UK, where advanced cardiac care systems are widely established. The Asia Pacific region is projected to witness the highest CAGR from 2025 to 2033, supported by rising healthcare investments, increasing cardiovascular disease prevalence, and improving access to surgical interventions in China, India, and Southeast Asia. Latin America and the Middle East & Africa are emerging markets, where rising cardiac awareness and public health initiatives are boosting demand.
Competitive Trends
The arterial filter market is moderately consolidated, with established players focusing on R&D, product integration, and clinical safety. TERUMO, Medtronic, and LivaNova lead the global market with robust portfolios, strong distribution networks, and innovation in filter material and flow dynamics. NIPRO and GETINGE provide integrated extracorporeal circulation systems bundled with arterial filters. Companies like Pall Corporation and SENKO Medical Instrument focus on precision microfiltration and biocompatibility. EUROSETS, Braile Biomedica, and Beijing MEDOS AT Biotechnology are expanding regionally with affordable, regulatory-compliant offerings. Competitive priorities include low priming volume, modular integration with CPB systems, and reduced inflammatory response through better design and coating technologies.
Historical & Forecast Period
This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Arterial Filter market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users & consumption volume, price, and value.
Geographical revenues generated by countries considered in the report
Micro and macro environment factors that are currently influencing the Arterial Filter market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.